FindTrial
Sign In

PEG-somatropin

BIOLOGICAL10 trials

Sponsors

Changchun GeneScience Pharmaceutical Co., Ltd.

Conditions

DwarfismDwarfism, PituitaryGHDGrowth Hormone DeficiencyGrowth RetardationShort Stature Children Born Small for Gestational Age (SGA)

Phase 2

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
Active, not recruitingNCT02375620
Changchun GeneScience Pharmaceutical Co., Ltd.Short Stature Children Born Small for Gestational Age (SGA)
Start: 2015-04-23End: 2025-12-31Target: 96Updated: 2025-05-25
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
Active, not recruitingNCT03255694
Changchun GeneScience Pharmaceutical Co., Ltd.Dwarfism
Start: 2017-05-12End: 2030-06-30Target: 360Updated: 2025-08-15

Phase 3

Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
CompletedNCT01495468
Changchun GeneScience Pharmaceutical Co., Ltd.Growth Hormone Deficiency
Start: 2007-03-31End: 2008-03-31Updated: 2017-07-31
A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency
NCT06024967
Changchun GeneScience Pharmaceutical Co., Ltd.GHD
Start: 2023-12-01End: 2025-09-01Target: 180Updated: 2023-09-11

Phase 4

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
NCT02314676
Changchun GeneScience Pharmaceutical Co., Ltd.Dwarfism, Pituitary
Start: 2014-11-30Target: 900Updated: 2014-12-11
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
NCT02380235
Changchun GeneScience Pharmaceutical Co., Ltd.Growth Hormone Deficiency
Start: 2014-12-31End: 2017-07-31Target: 600Updated: 2017-06-16
Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
NCT02908958
Changchun GeneScience Pharmaceutical Co., Ltd.Growth Hormone Deficiency
Start: 2014-11-30Target: 900Updated: 2017-06-14
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT02976675
Changchun GeneScience Pharmaceutical Co., Ltd.Growth Hormone Deficiency
Start: 2015-01-31Target: 600Updated: 2017-06-16
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT03249480
Changchun GeneScience Pharmaceutical Co., Ltd.Growth Hormone Deficiency
Start: 2015-01-31Target: 900Updated: 2017-08-15
Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
NCT03290235
Changchun GeneScience Pharmaceutical Co., Ltd.Growth Retardation
Start: 2017-03-01End: 2021-09-30Target: 1500Updated: 2017-12-12

Related Papers

A Phase 2 Study of PEGylated Recombinant Human Growth Hormone for 52 Weeks in Short Children Born Small for Gestational Age in China
Clinical Endocrinology2024-11-081 citations
Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study
The Journal of Clinical Endocrinology & Metabolism2023-01-2123 citations
Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: A randomized, dose-comparison study
Frontiers in Pharmacology2022-08-1111 citations
Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study.
2022-08-0910 citations
Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial
Frontiers in Endocrinology2021-11-2513 citations